Q4 2024 Holdings
Filed 2025-02-14 | 59 holdings | $133.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $6.8M | 246,700 | 5.1% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $6.4M | 8,247 | 4.8% |
| Geron Corp(GERN) | COM | 374163103 | $5.6M | 1,561,152 | 4.2% |
| Humana Inc(HUM) | COM | 444859102 | $4.6M | 18,066 | 3.4% |
| Guardant Health Inc(GH) | COM | 40131M109 | $4.5M | 147,800 | 3.4% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $4.5M | 1,083,487 | 3.4% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $4.4M | 69,072 | 3.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $4.2M | 318,900 | 3.2% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $4.2M | 218,700 | 3.1% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $4.1M | 151,965 | 3.1% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $3.9M | 7,427 | 2.9% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $3.8M | 119,467 | 2.9% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $3.7M | 65,200 | 2.8% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $3.6M | 40,500 | 2.7% |
| Natera Inc(NTRA) | COM | 632307104 | $3.6M | 22,450 | 2.7% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $3.5M | 77,285 | 2.6% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $3.3M | 77,439 | 2.5% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $3.2M | 40,580 | 2.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $3.1M | 65,883 | 2.3% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $2.8M | 31,800 | 2.1% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $2.7M | 29,700 | 2.1% |
| Summit Therapeutics Inc(SMMT) | COM | 86627T108 | $2.3M | 130,412 | 1.7% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $2.3M | 137,716 | 1.7% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $2.2M | 81,473 | 1.6% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $2.1M | 40,123 | 1.6% |
| Savara Inc(SVRA) | COM | 805111101 | $2.1M | 699,698 | 1.6% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $2.1M | 61,367 | 1.6% |
| Penumbra Inc(PEN) | COM | 70975L107 | $2.1M | 9,000 | 1.6% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $2.0M | 159,552 | 1.5% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $1.9M | 68,608 | 1.4% |
| DR Reddys Labs LTD(RDY) | ADR | 256135203 | $1.9M | 117,500 | 1.4% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $1.8M | 10,000 | 1.4% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $1.8M | 225,323 | 1.3% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $1.6M | 28,178 | 1.2% |
| Karyopharm Therapeutics Inc | NOTE 3.000%10/1 | 48576UAA4 | $1.6M | 2,000,000 | 1.2% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $1.4M | 103,504 | 1.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $1.3M | 283,599 | 1.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $1.2M | 113,096 | 0.9% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $1.2M | 37,600 | 0.9% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $1.2M | 26,081 | 0.9% |
| Alvotech(ALVO) | ORDINARY SHARES | L01800108 | $1.2M | 90,100 | 0.9% |
| Vyne Therapeutics Inc(VYNE) | COM | 92941V308 | $1.2M | 353,434 | 0.9% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $1.1M | 256,373 | 0.8% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $1.1M | 28,159 | 0.8% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $993.3K | 1,097,999 | 0.7% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $965.5K | 389,333 | 0.7% |
| Annexon Inc(ANNX) | COM | 03589W102 | $743.0K | 144,830 | 0.6% |
| Veru Inc(VERUEUR) | COM | 92536C103 | $739.5K | 1,117,600 | 0.6% |
| Acelyrin Inc | COM | 00445A100 | $736.1K | 234,435 | 0.6% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $662.9K | 54,738 | 0.5% |